Home
/
Xenon Pharmaceuticals Inc.
/
Financials
/
Quarterly
Xenon Pharmaceuticals Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Xenon Pharmaceuticals Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2017
Sep 30, 2017
$264.0K
Nov 7, 2017
Q2
2017
Jun 30, 2017
$15.0K
Aug 3, 2017
Q1
2017
Mar 31, 2017
$16.0K
May 9, 2017
Q3
2017
Sep 30, 2016
$413.0K
Nov 7, 2017
Q2
2017
Jun 30, 2016
$413.0K
Aug 3, 2017
Q1
2017
Mar 31, 2016
$601.0K
May 9, 2017
Q3
2016
Sep 30, 2015
$4.29M
Nov 3, 2016
Q2
2016
Jun 30, 2015
$4.05M
Aug 3, 2016
Q1
2016
Mar 31, 2015
$4.01M
May 10, 2016
Q3
2015
Sep 30, 2014
$13.19M
Nov 10, 2015
Q2
2015
Jun 30, 2014
$5.30M
Aug 13, 2015
Q3
2014
Sep 30, 2013
$10.79M
Dec 15, 2014
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2018
Sep 30, 2017
$264.0K
Nov 6, 2018
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($90.90M)
Nov 3, 2025
Q3
2025
Jun 30, 2025
($84.71M)
Nov 3, 2025
Q2
2025
Jun 30, 2025
($84.71M)
Aug 11, 2025
Q3
2025
Mar 31, 2025
($65.05M)
Nov 3, 2025
Q2
2025
Mar 31, 2025
($65.05M)
Aug 11, 2025
Q1
2025
Mar 31, 2025
($65.05M)
May 12, 2025
Q3
2025
Sep 30, 2024
($62.79M)
Nov 3, 2025
Q2
2025
Jun 30, 2024
($57.92M)
Aug 11, 2025
Q3
2025
Jun 30, 2024
($57.92M)
Nov 3, 2025
Q1
2025
Mar 31, 2024
($47.93M)
May 12, 2025
Q2
2025
Mar 31, 2024
($47.93M)
Aug 11, 2025
Q3
2025
Mar 31, 2024
($47.93M)
Nov 3, 2025
Q3
2024
Sep 30, 2023
($48.46M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($47.46M)
Aug 8, 2024
Q3
2024
Jun 30, 2023
($47.46M)
Nov 12, 2024
Q3
2024
Mar 31, 2023
($41.73M)
Nov 12, 2024
Q2
2024
Mar 31, 2023
($41.73M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($41.73M)
May 9, 2024
Q3
2023
Sep 30, 2022
($37.15M)
Nov 8, 2023
Q3
2023
Jun 30, 2022
($31.16M)
Nov 8, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($96.34M)
Nov 3, 2025
Q2
2025
Jun 30, 2025
($94.23M)
Aug 11, 2025
Q1
2025
Mar 31, 2025
($72.74M)
May 12, 2025
Q3
2025
Sep 30, 2024
($73.68M)
Nov 3, 2025
Q2
2025
Jun 30, 2024
($69.10M)
Aug 11, 2025
Q1
2025
Mar 31, 2024
($59.04M)
May 12, 2025
Q3
2024
Sep 30, 2023
($55.68M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($55.62M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($49.05M)
May 9, 2024
Q3
2023
Sep 30, 2022
($38.13M)
Nov 8, 2023
Q2
2023
Jun 30, 2022
($30.32M)
Aug 9, 2023
Q1
2023
Mar 31, 2022
($17.37M)
May 9, 2023
Q3
2022
Sep 30, 2021
($15.60M)
Nov 8, 2022
Q2
2022
Jun 30, 2021
($22.50M)
Aug 9, 2022
Q1
2022
Mar 31, 2021
($16.06M)
May 10, 2022
Q3
2021
Sep 30, 2020
($9.70M)
Nov 10, 2021
Q2
2021
Jun 30, 2020
($646.0K)
Aug 11, 2021
Q1
2021
Mar 31, 2020
($8.03M)
May 11, 2021
Q3
2020
Sep 30, 2019
($8.95M)
Nov 5, 2020
Q2
2020
Jun 30, 2019
($10.51M)
Aug 6, 2020